A. Jungwirth

Publications76
h-index25
Citations3,457
Highly Influential Citations93
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • A. Schally
  • 1,799 Publications • 61,659 Citations
  • W. Weidner
  • 700 Publications • 18,123 Citations
  • E. Nieschlag
  • 979 Publications • 45,987 Citations
  • G. Halmos
  • 238 Publications • 8,216 Citations
  • Publications
  • Influence
European Association of Urology guidelines on Male Infertility: the 2012 update.
Guidelines on Male Infertility
TLDR
52. Weidner W, Schiefer HG, Garbe C. Acute nongonococcal epididymitis.
Molecular Structure of Salt Solutions: A New View of the Interface with Implications for Heterogeneous Atmospheric Chemistry
Most salts raise the surface tension of water. Interpretation of this phenomenon via the Gibbs adsorption equation has led to the commonly held belief that the ions are repelled from the air/solution…
Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent.
Doxorubicin (DOX) and its daunosamine-modified derivative, 2-pyrrolino-DOX, which is 500-1000 times more active than DOX, were incorporated into agonistic and antagonistic analogs of luteinizing…
Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II.
Transurethral needle ablation of the prostate for the treatment of benign prostatic hyperplasia: a collaborative multicentre study.
TLDR
In the medium to long term, TUNA therapy will be a useful low-morbidity alternative for patients with symptomatic BPH if these early promising results are maintained.
Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone.
TLDR
The results indicate that GH-RH antagonist MZ-4-71 suppresses growth of PC-3, DU-145 and Dunning AT-1 androgen-independent prostate cancers, through diminution of GH release and the resulting decrease in the secretion of hepatic IGF-I, or through mechanisms involving a lowering of tumour IGF-i levels and possibly an inhibition of tumours IGF- I and IGF-II production.
Growth hormone-releasing hormone antagonist MZ-4-71 inhibits in vivo proliferation of Caki-I renal adenocarcinoma.
TLDR
It is demonstrated that GH-RH antagonist MZ-4-71 can significantly inhibit the growth of Caki-I RCC and suggests that this compound could be considered for the therapy of recurrent or metastatic RCC.
One 10‐core prostate biopsy is superior to two sets of sextant prostate biopsies
TLDR
To compare the efficiency of different transrectal ultrasonography (TRUS)‐guided prostate biopsy techniques for detecting prostate cancer, a large number of patients are treated with both TRUS and conventional biopsy methods.
EAU guidelines on male infertility.
...
1
2
3
4
5
...